New Key Statistics Module, Z-Score and F-Score
NAS:MIRM Key Ratios
| Market Cap $ M | 1,217.54 |
| Enterprise Value $ M | 1,239.36 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.86 |
| Price/Sales | 5.77 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 186.00 |
| EPS (TTM) $ | -4.02 |
| Beneish M-Score | -2.06 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -8.41 |
| EV-to-EBITDA | -9.08 |
| PEG | -- |
| Shares Outstanding M | 47.12 |
| Net Margin (%) | -87.68 |
| Operating Margin % | -58.57 |
| Pre-tax Margin (%) | -87.15 |
| Quick Ratio | 4.19 |
| Current Ratio | 4.45 |
| ROA % (ttm) | -33.66 |
| ROE % (ttm) | -92.90 |
| ROIC % (ttm) | -54.74 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.73 |
MIRM Number of Guru Trades
MIRM Volume of Guru Trades
Gurus Latest Trades with NAS:MIRM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:MIRM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Mirum Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:MIRM
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers